Interactions of iron with reactive intermediates of oxygen and nitrogen

Developmental Neuroscience

Volumn 24, Issue 2-3, 2002, Pages 134-142

  Nappi, Anthony J ^a   Vass, Emily ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Iron hormeostasis; Oxidative and nitrosative damage

Indexed keywords

IRON; NEUROMELANIN; NITROGEN; REACTIVE OXYGEN METABOLITE;

ARTICLE; BRAIN PROTECTION; CYTOTOXICITY; HOMEOSTASIS; IRON METABOLISM; MACROPHAGE; MOLECULAR INTERACTION; NEUROTOXICITY; PRIORITY JOURNAL;

HUMANS; IRON; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 0036970050     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065697     Document Type: Article

References (46)

1. Alderton WK, Cooper CE, Knowles RG (2001): Nitric oxide synthases: Structure, function and inhibition. Biochem J 357:593-615.
2. Allen DR, Wallis GL, McCay PB (1994): Catechol adrenergic agents enhance hydroxyl radical generation in xanthine oxidase systems containing ferritin - Implications for ischemia reperfusion. Arch Biochem Biophys 315:235-243.
3. Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR (1997): MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 15:29-35.
4. Beckman JS (1996): The physiological and pathological chemistry of nitric oxide; in Lancaster JRJ (ed): Nitric Oxide: Principles and Actions. San Diego, Academic Press.
5. Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, Riederer P, Becker G (2001): Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 79:225-236.
6. Boldt DH (1999): New perspectives on iron: An introduction. Am J Med Sci 318:207-212.
7. Chiueh CC (2001): Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 25:138-147.
8. Connor JR, Menzies SL, Burdo JR, Boyer PJ (2001): Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118-129.
9. d'Ischia M, Costantini C (1995): Nitric oxide-induced nitration of catecholamine neurotransmitters: A key to neuronal degeneration? Bioorg Med Chem 3:923-927.
10. Drapier JC, Hirling H, Wietzerbin H, Kaldy P, Kuhn LC (1993): Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J 12:3643-3650.
11. Eide D, Davis-Kaplan S, Jordan I, Snipe D, Kaplan J (1992): Regulation of iron uptake in Saccharomyces cerevisae. The ferrireductase and Fe(II) transporter are regulated independently. J Biol Chem 267:20774-20781.
12. Emery T (ed) (1987): Reductive Mechanisms of Iron Transport. New York, VCH.
13. Emery TF (1991): Iron and Your Health: Facts and Fallacies. Boca Raton, CRC Press.
14. Feher J, Csomos G, Vereckei A (1987): Free Radical Reactions in Medicine. Berlin, Springer.
15. Floor E (2000): Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease. Cell Mol Biol (Noisy-le-grand) 46:709-720.
16. Focht SJ, Snyder BS, Beard JL, Van Gelder W, Wil-liams LR, Connor JR (1997): Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience 79:255-261.
17. Gerlach M, Youdim MBH, Riederer P (2000): Brain iron and other trace metals in neurode-generative diseases. Neurotoxic factors in Parkinson's disease and related disorders. In press.
18. Graham JM, Paley MNJ, Grunewald RA, Hoggard N, Griffiths PD (2000): Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123:2423-2431.
19. Halliwell B (2001): Role of free radicals in the neu-rodegenerative diseases - Therapeutic implications for antioxidant treatment. Drugs Aging 18:685-716.
20. Halliwell B, Gutteridge JMC (1997): Lipid peroxidation in brain homogenates - the role of iron and hydroxyl radicals. J Neurochem 69:1330.
21. Hibbs JB Jr (2002): Infection and nitric oxide. J Infect Dis 185:9-15.
22. Hibbs JB Jr, Vavrin Z, Taintor RR (1987):L-Argi-nine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138:550-565.
23. Jellinger KA (1999): The role of iron in neurode-generation: prospects for pharmacotherapy of Parkinson's disease. Drugs Aging 14:115-140.
24. Kaplan P, Doval M, Majerova Z, Lehotsky J, Ra-cay P (2000): Iron-induced lipid peroxidation and protein modification in endoplasmic reticulum membranes. Protection by stobadine. Int J Biochem Cell Biol 32:539-547.
25. Karg E, Orvos H, Papp A, Beck N, Turi S, Nemeth I (2001): Ferroxidases and xanthine oxidase in plasma of healthy newborn infants. Free Radic Res 35, 555-561.
26. Lancaster JRJ, Hibbs JB Jr (1990): EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA 87:1223-1237.
27. Lash A, Saleem A (1995): Iron metabolism and its regulation. A review. Ann Clin Lab Sci 25:20-30.
28. Nappi AJ, Vass E (1998a): Hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide. Biochim Bio-phys Acta 1380:53-63.
29. Nappi AJ, Vass E (1998b): Hyroxyl radical formation via-iron-mediated Fenton chemistry is inhibited by methylated catechols. Biochim Bio-phys Acta 1425:159-167.
30. Nappi AJ, Vass E (2000): Iron, metalloenzymes and cytotoxic reactions. Cell Mol Biol (Noisy-le-grand) 46:637-647.
31. Neilands JB (ed): (1976): Siderophores: Biochemical Ecology and Mechanism of Iron Transport in Enterobacteria. Washington, American Chemical Society.
32. Petrat F, De Groot H, Sustmann R, Rauen U (2002): The chelatable iron pool in living cells: A methodologically defined quantity. Biol Chem 383:489-502.
33. 2 formation. FASEB J 14:1953-1964.
34. Riley PA (1988): Radicals in melanin biochemistry. Ann NY Acad Sci 551:111-119; discussion 119-120.
35. Sayre LM, Perry G, Smith MA (1999): Redox metals and neurodegenerative disease. Curr Opin Chem Biol 3:220-225.
36. Stamler JS (1994): Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78:931.
37. Symons MCR, Gutteridge JMC (1998): Free Radicals and Iron: Chemistry, Biology, and Medicine. Oxford, Oxford University Press.
38. Thomas SR, Mohr D, Stockr R (1994): Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-primed mononuclear phagocytes. J Biol Chem 269:14457.
39. Velez-Pardo C, Jimenez Del Rio M, Verschueren H, Ebinger G, Vauquelin G (1997): Dopamine and iron induce apoptosis in PC12 cells. Phar-macol Toxicol 80:76-84.
40. Wade R, Castro C (1990): Redox reactivity of iron (III) porphyrins and heme proteins with nitric oxide. Nitrosyl transfer to carbon, oxygen, nitrogen and sulfur. Chem Res Toxicol 3:289-291.
41. Waggoner DJ, Bartnikas TB, Gitlin JD (1999): The role of copper in neurodegenerative disease. Neurobiol Dis 6:221-230.
42. Weiss G, Goossen B, Doppler W, et al (1993): Translational regulation via iron-responsive elements by nitric oxide/NO-synthase pathway. EMBO J 12:3651-3657; 12:3651-3657.
43. Weiss G, Werner-Felmayer G, Werner ER, Grune-wald K, Wachter H, Hentze MW (1994): Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 180: 969-976.
44. Weiss G, Widner B, Zoller H, Schobersberger W, Fuchs D (1998): Immune response and iron metabolism. Br J Anaesth 81:6-9.
45. Wink DA, Mitchell JB (1998): Chemical biology of nitric oxide: Insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide.Free Radic Biol Med 25:434-456.
46. Wink DA, Miranda KM, Espey MG (2001): Cyto-toxicity related to oxidative and nitrosative stress by nitric oxide. Exp Biol Med 226:621-623.